These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23566899)

  • 1. Prediction of dose-hepatotoxic response in humans based on toxicokinetic/toxicodynamic modeling with or without in vivo data: a case study with acetaminophen.
    Péry AR; Brochot C; Zeman FA; Mombelli E; Desmots S; Pavan M; Fioravanzo E; Zaldívar JM
    Toxicol Lett; 2013 Jun; 220(1):26-34. PubMed ID: 23566899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BK/TD models for analyzing in vitro impedance data on cytotoxicity.
    Teng S; Barcellini-Couget S; Beaudouin R; Brochot C; Desousa G; Rahmani R; Pery AR
    Toxicol Lett; 2015 Jun; 235(2):96-106. PubMed ID: 25827406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of in vitro data from three dimensionally cultured HepaRG cells and physiologically based pharmacokinetic modeling for assessment of acetaminophen hepatotoxicity.
    Zhang C; Zhang Q; Li J; Yu L; Li F; Li W; Li Y; Peng H; Zhao J; Carmichael PL; Wang Y; Peng S; Guo J
    Regul Toxicol Pharmacol; 2020 Jul; 114():104661. PubMed ID: 32315674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A transcriptomics-based hepatotoxicity comparison between the zebrafish embryo and established human and rodent in vitro and in vivo models using cyclosporine A, amiodarone and acetaminophen.
    Driessen M; Vitins AP; Pennings JL; Kienhuis AS; Water Bv; van der Ven LT
    Toxicol Lett; 2015 Jan; 232(2):403-12. PubMed ID: 25448281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling.
    Louisse J; Bosgra S; Blaauboer BJ; Rietjens IM; Verwei M
    Arch Toxicol; 2015 Jul; 89(7):1135-48. PubMed ID: 24935252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
    Yoon M; Kedderis GL; Yan GZ; Clewell HJ
    Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatoprotective ability of a novel botanical formulation on mild liver injury in rats produced by acute acetaminophen and/or alcohol ingestion.
    Echard BW; Talpur NA; Fan AY; Bagchi D; Preuss HG
    Res Commun Mol Pathol Pharmacol; 2001; 110(1-2):73-85. PubMed ID: 12090358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a systems model of drug-induced liver injury (DILIsym(®)) to elucidate the mechanistic differences between acetaminophen and its less-toxic isomer, AMAP, in mice.
    Howell BA; Siler SQ; Watkins PB
    Toxicol Lett; 2014 Apr; 226(2):163-72. PubMed ID: 24560604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Low-Level Drug Effects Using Real-Time, in vitro Measurement of Oxygen Consumption Rate.
    Neal A; Rountree AM; Philips CW; Kavanagh TJ; Williams DP; Newham P; Khalil G; Cook DL; Sweet IR
    Toxicol Sci; 2015 Dec; 148(2):594-602. PubMed ID: 26396153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
    Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
    Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional HepaRG model as an attractive tool for toxicity testing.
    Leite SB; Wilk-Zasadna I; Zaldivar JM; Airola E; Reis-Fernandes MA; Mennecozzi M; Guguen-Guillouzo C; Chesne C; Guillou C; Alves PM; Coecke S
    Toxicol Sci; 2012 Nov; 130(1):106-16. PubMed ID: 22843569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man.
    Louisse J; de Jong E; van de Sandt JJ; Blaauboer BJ; Woutersen RA; Piersma AH; Rietjens IM; Verwei M
    Toxicol Sci; 2010 Dec; 118(2):470-84. PubMed ID: 20833708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHOP is a critical regulator of acetaminophen-induced hepatotoxicity.
    Uzi D; Barda L; Scaiewicz V; Mills M; Mueller T; Gonzalez-Rodriguez A; Valverde AM; Iwawaki T; Nahmias Y; Xavier R; Chung RT; Tirosh B; Shibolet O
    J Hepatol; 2013 Sep; 59(3):495-503. PubMed ID: 23665281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach.
    Zurlinden TJ; Reisfeld B
    Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):267-80. PubMed ID: 25636597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism by conjugation appears to confer resistance to paracetamol (acetaminophen) hepatotoxicity in the cynomolgus monkey.
    Yu H; Barrass N; Gales S; Lenz E; Parry T; Powell H; Thurman D; Hutchison M; Wilson ID; Bi L; Qiao J; Qin Q; Ren J
    Xenobiotica; 2015 Mar; 45(3):270-7. PubMed ID: 25335570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of small doses of various drug vehicles on acetaminophen-induced liver injury.
    Kelava T; Cavar I; Culo F
    Can J Physiol Pharmacol; 2010 Oct; 88(10):960-7. PubMed ID: 20962895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fructose-induced hypertriglyceridemia on hepatorenal toxicity of acetaminophen in rats: role of pharmacokinetics and metabolism of acetaminophen.
    Ishida K; Sakazume M; Watanabe M; Hirai N; Ikegami H; Sakai T; Doi K
    Exp Toxicol Pathol; 1997 Aug; 49(3-4):207-15. PubMed ID: 9314055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pharmacokinetic profile of valsartan in humans based on in vitro uptake-transport data.
    Poirier A; Cascais AC; Funk C; Lavé T
    Chem Biodivers; 2009 Nov; 6(11):1975-87. PubMed ID: 19937834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-animal approaches for toxicokinetics in risk evaluations of food chemicals.
    Punt A; Peijnenburg AACM; Hoogenboom RLAP; Bouwmeester H
    ALTEX; 2017; 34(4):501-514. PubMed ID: 28403478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.